Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions frequently emphasize mitochondrial dysfunction as a central element in Parkinson's disease, with phrases like 'key factor' and 'therapeutic potential' illustrating optimism about future treatments. The tone is mostly informative and supportive, with mentions of prevention strategies and implications for mental health supporting the overall perception that this research is crucial for advancing understanding and therapy development.
Most posts acknowledge mitochondrial dysfunction as a key factor and support the idea that it could be a target for therapy, reflecting general consensus with the article's focus.
Posts demonstrate high curiosity, with many emphasizing the importance of mitochondrial health and potential for prevention or treatment, indicating strong interest.
While some posts comment on the implications and importance, few delve into detailed mechanisms or critique, showing moderate to deep engagement but not extensive discussion.
Several posts highlight the significance of understanding mitochondrial dysfunction for therapeutic development, suggesting moderate perceived impact but not overwhelmingly transformative.
People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognitive impairment, and other "mental health" symptoms. Why? "Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark" https://t.co/oviqMvo6fa
Researchers from @NUFeinbergMed provide a useful review of mitochondrial dysfunction in #Parkinsons https://t.co/AgejlnRK27 https://t.co/uwXznaQHuZ
'#Mitochondrial dysfunction in #Parkinsons disease – a key disease hallmark with therapeutic potential' Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, Fanni F. Geibl @Uni_MR @NUFeinbergMed https://t.co/ojO6WCpmJ2 https://t.co/IlsOrl16eH
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
Mitochondrial dysfunction is a major factor in Parkinson's disease development, with damaged electron transport chains and increased oxidative stress contributing to neuron death. Understand the challenges and future…
This video explores how mitochondrial issues contribute to Parkinson's disease development, highlighting the difficulties in current treatments targeting these problems and emphasizing the need for further research into…
@KitChri75116757 @dr_andrealove Genetics load the gun, lifestyle pulls the trigger. Mitochondrial dysfunction is a key factor in the development of Parkinson's disease. Therefore preventing the disease, not treating the neurodegeneration and subsequent disease would be ideal
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
Another reason to take care of your mitochondria. “Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease” https://t.co/nrAiBaQoxE
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
RT @ChrisPalmerMD: People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognit…
People with Parkinson's disease are more likely to have depression, anxiety, insomnia, hallucinations, delusions, cognitive impairment, and other "mental health" symptoms. Why? "Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark" https://t.co/oviqMvo6fa
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential https://t.co/W4a0T0eWbu https://t.co/chS60GoVu2
'#Mitochondrial dysfunction in #Parkinsons disease – a key disease hallmark with therapeutic potential' Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, Fanni F. Geibl @Uni_MR @NUFeinbergMed https://t.co/ojO6WCpmJ2 https://t.co/IlsOrl16eH
RT @Ingentium_PD: Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential. https://t.co/1U4LQR…
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential. https://t.co/1U4LQRl2bn https://t.co/AqPs45SdqH
Mitochondrial dysfunction in Parkinson's disease – a key disease ... - Molecular Neurodegeneration https://t.co/EVqlwwRl9c
RT @ScienceofPD: Researchers from @NUFeinbergMed provide a useful review of mitochondrial dysfunction in #Parkinsons https://t.co/AgejlnRK…
RT @ScienceofPD: Researchers from @NUFeinbergMed provide a useful review of mitochondrial dysfunction in #Parkinsons https://t.co/AgejlnRK…
Researchers from @NUFeinbergMed provide a useful review of mitochondrial dysfunction in #Parkinsons https://t.co/AgejlnRK27 https://t.co/uwXznaQHuZ
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential https://t.co/K7ptRK6QYf #IronBiology #BioIron #Iron